Search Results for: arthritis

Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension.

Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension.

Tuberculosis Literature
Publication date: Jan 31, 2025 Assess long-term safety, tolerability and efficacy of bimekizumab in ankylosing spondylitis (radiographic axial spondyloarthritis (r-axSpA)). Patients with active r-axSpA completing the dose-ranging 48-week randomised controlled ... Read more

Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-Related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Tuberculosis News
Publication date: Nov 26, 2024 The purpose of this study is to assess plasma bimekizumab concentrations following subcutaneous (sc) bimekizumab administration. Concepts Keywords Arthritis Arthritis Pediatric Bimekizumab Pharmacokinetics Recruiting Years ... Read more